Advertisement
Research
In countries such as Cyprus the financial crisis and the recession have severely affected the funding and priority setting of the health care system. There is evidence highlighting the importance of population...
Cost Effectiveness and Resource Allocation 2017 15:16
Published on: 9 August 2017
Research
As treatments for chronic hepatitis C are moving away from interferon-containing regimens, the most appropriate allocation of resources to higher cost, interferon-free, direct-acting antiviral (DAA) regimens n...
Cost Effectiveness and Resource Allocation 2017 15:15
Published on: 21 July 2017
Research
In 2013, 78% of malaria deaths occurred in children aged 5 years and below, in sub-Saharan Africa. Treatment of severe malaria requires a health facility with inpatient care. However, in most sub-Sahara Africa...
Cost Effectiveness and Resource Allocation 2017 15:14
Published on: 14 July 2017
Research
This study evaluated the potential cost-effectiveness of cervical cancer screening in HIV treatment clinics in Nairobi, Kenya.
Cost Effectiveness and Resource Allocation 2017 15:13
Published on: 14 July 2017
Research
Innovations that improve the affordability, accessibility, or effectiveness of health care played a major role in the Millennium Development Goal achievements and will be critical for reaching the ambitious ne...
Cost Effectiveness and Resource Allocation 2017 15:12
Published on: 12 July 2017
Research
In Italy HPV vaccination with the quadrivalent vaccine (Gardasil®) is offered actively and free of charge to girls aged 12 since 2007. A nine-valent vaccine (Gardasil 9®) received the European market authorizatio...
Cost Effectiveness and Resource Allocation 2017 15:11
Published on: 11 July 2017
Review
Malaria continues to be a public health problem despite past and on-going control efforts. For sustenance of control efforts to achieve the malaria elimination goal, it is important that the most cost-effectiv...
Cost Effectiveness and Resource Allocation 2017 15:10
Published on: 1 July 2017
Research
This study evaluates the cost-effectiveness of the DAZT program for scaling up treatment of acute child diarrhea in Gujarat India using a net-benefit regression framework.
Cost Effectiveness and Resource Allocation 2017 15:9
Published on: 8 June 2017
Methodology
Ofatumumab (Arzerra®, Novartis) is a treatment for chronic lymphocytic leukemia refractory to fludarabine and alemtuzumab [double refractory (DR-CLL)]. Ofatumumab was licensed on the basis of an uncontrolled Phas...
Cost Effectiveness and Resource Allocation 2017 15:8
Published on: 26 May 2017
Review
This study aims to summarise and describe the evolution of published economic evaluations of vaccines in Canada, thereby outlining the current state of this expanding and meaningful research.
Cost Effectiveness and Resource Allocation 2017 15:7
Published on: 5 May 2017
Research
This study is an initial effort to examine the dynamics of efficiency and productivity in Greek public hospitals during the first phase of the crisis 2009–2012. Data were collected by the Ministry of Health af...
Cost Effectiveness and Resource Allocation 2017 15:6
Published on: 26 April 2017
Methodology
Mobile and wireless technology for health (mHealth) has the potential to improve health outcomes by addressing critical health systems constraints that impede coverage, utilization, and effectiveness of health...
Cost Effectiveness and Resource Allocation 2017 15:5
Published on: 17 April 2017
Research
In resource-limited settings with a high prevalence of human immunodeficiency virus (HIV) infection such as Zambia, decentralization of HIV/acquired immunodeficiency syndrome (HIV/AIDS) treatment and care with...
Cost Effectiveness and Resource Allocation 2017 15:4
Published on: 12 April 2017
Research
Health care systems around the world have started to develop pharmacists prescribing for minor ailments (PPMA) programs. These programs aim to improve the efficiency of care, reduce physician visits, and incre...
Cost Effectiveness and Resource Allocation 2017 15:3
Published on: 11 April 2017
Research
Neonatal mortality remains unacceptably high in many low and middle-income countries, including India. A community mobilisation intervention using participatory learning and action with women’s groups facilita...
Cost Effectiveness and Resource Allocation 2017 15:2
Published on: 21 March 2017
Review
Economic evidence is influential in health technology assessment world-wide. Clinical Practice Guidelines (CPG) can enable economists to include economic information on health care provision. Application of ec...
Cost Effectiveness and Resource Allocation 2017 15:1
Published on: 10 February 2017
Research
In Nepal, pre-eclampsia/eclampsia (PE/E) causes an estimated 21% of maternal deaths annually and contributes to adverse neonatal birth outcomes. Calcium supplementation has been shown to reduce the risk of PE/...
Cost Effectiveness and Resource Allocation 2016 14:13
Published on: 28 December 2016
Review
Long-term care for older people is provided in both residential and non-residential settings, with residential settings tending to cater for individuals with higher care needs. Evidence relating to the costs a...
Cost Effectiveness and Resource Allocation 2016 14:12
Published on: 12 December 2016
Research
Zoledronic acid and denosumab were funded by the Australian government for the management of osteoporosis at an equivalent price to alendronate. The price of alendronate has declined by around 65 %, but the pr...
Cost Effectiveness and Resource Allocation 2016 14:11
Published on: 13 October 2016
Research
The coverage of prevention and treatment strategies for ischemic heart disease and stroke is very low in Ethiopia. In view of Ethiopia’s meager healthcare budget, it is important to identify the most cost-effe...
Cost Effectiveness and Resource Allocation 2016 14:10
Published on: 12 August 2016
Research
Schizophrenia remains a priority condition in mental health policy and service development because of its early onset, severity and consequences for affected individuals and households.
Cost Effectiveness and Resource Allocation 2016 14:9
Published on: 8 July 2016
Research
Human papilloma virus (HPV) vaccination in Nigeria will require substantial financing due to high cost of HPV vaccine and inexistence of structures to support adolescent vaccination. Alternative sources are ne...
Cost Effectiveness and Resource Allocation 2016 14:8
Published on: 6 June 2016
Research
To conduct a cost-utility analysis of ranibizumab versus aflibercept for the treatment of patients with visual impairment due to diabetic macular edema (DME) in the Greek setting.
Cost Effectiveness and Resource Allocation 2016 14:7
Published on: 14 April 2016
Research
The objective of this analysis was to determine the value (incremental cost/increment benefit) of a brain LITT system versus employing current surgical options recommended by NCCN guidelines, specifically open...
Cost Effectiveness and Resource Allocation 2016 14:6
Published on: 21 March 2016
Reviewer acknowledgement
The editors of Cost Effectiveness and Resource Allocation would like to thank all our reviewers who have contributed to the journal in volume 13 (2015).
Cost Effectiveness and Resource Allocation 2016 14:5
Published on: 11 March 2016
